𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reference distributions for alpha2-macroglobulin: A practical, simple and clinically relevant approach in a large cohort

✍ Scribed by Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas B. Ledue; Wendy Y. Craig


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
152 KB
Volume
18
Category
Article
ISSN
0887-8013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In this 11th article in a series, reference values of serum levels alpha~2~‐macroglobulin α~2~M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New England that were tested in our laboratory between 1994 and 2000. Measurements were standardized against Certified Reference Material (CRM 470)/Reference Preparation for Proteins in Human Serum (RPPHS) and the results analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C‐reactive protein >10 mg/L) were excluded in one leg of the study and included in the other, confirming that α~2~M does not respond to acute phase drive in man. Nephrotic syndrome, diabetes mellitus, and chronic liver disease have significant effect on levels of α~2~M. Dramatic changes occur during life with males higher from birth to age 12, females thereafter have higher values until the ninth decade. When values were expressed as multiples of the age‐ and gender‐specific median levels, the resulting distributions fitted a log‐Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement thus simplifying interpretation. J. Clin. Lab. Anal. 18:139–147, 2004. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Reference distributions for immunoglobul
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Serum immunoglobulins are measured millions of times each year, yet clinical interpretations remain hampered by inadequate age- and gender-specific reference limits. In order to provide more reliable and comprehensive reference distributions for IgA, IgG, and IgM measurements, we analyzed automated

Reference distributions for serum iron a
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract The principal considerations driving iron status evaluation are clinical concern for anemia and the possibility of iron‐storage disease. Most often, the circulating levels of transferrin (or total iron binding capacity) and serum iron are measured and the percentage of transferrin satur

Reference distributions for complement p
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract The two serum proteins of the complement cascade in the highest concentrations, C3 and C4, respond to various conditions in much the same manner as do other positive acute‐phase proteins. A major difference is that they are relatively sluggish in response to cytokine drive, requiring se

Reference distributions for the negative
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Olga Navolotskaia; Thomas 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Inflammation is associated with diverse clinical conditions accompanied by characteristic changes in serum levels of the acutephase proteins that can be used to stage the inflammatory process and evaluate the impact of treatment. Some acute-phase proteins increase during inflammation, while others,

Reference distributions for apolipoprote
✍ Robert F. Ritchie; Glenn E. Palomaki; Louis M. Neveux; Thomas B. Ledue; Wendy Y. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

## Abstract The two serum apolipoproteins in the highest concentrations, apolipoprotein (apo) AI and apolipoprotein B, and the apolipoprotein B/AI ratio are measured to assess clinical risk for atherosclerotic heart and peripheral vascular diseases. The study is based on a cohort of over 37,000 Cau